Guides

Each guide cites primary sources (FDA, CMS, state boards and manufacturers) and shows when it was last reviewed. None of them give dosing advice or tell you whether a treatment is right for you.

• Is compounded semaglutide or tirzepatide still legal?

  Shortage end dates, 503A vs 503B rules, FDA's 2025–2026 enforcement actions, and warning signs to watch for with compounded GLP-1s.

  Last reviewed September 17, 2026

• Wegovy vs Zepbound vs compounded GLP-1s: what's the difference?

  A factual comparison of Wegovy, Zepbound, the Foundayo pill and compounded semaglutide or tirzepatide: ingredients, FDA status and approved uses.

  Last reviewed September 17, 2026

• Brand-name GLP-1 self-pay options: LillyDirect, NovoCare and TrumpRx

  Cash prices for Zepbound, Foundayo and Wegovy from LillyDirect, NovoCare and TrumpRx as of September 2026, and how self-pay differs from insurance.

  Last reviewed September 17, 2026

• Does insurance, Medicare or Medicaid cover GLP-1 weight-loss drugs?

  How Medicare Part D, the Medicare GLP-1 Bridge, the BALANCE Model, Medicaid and employer plans treat obesity GLP-1s, as of September 2026.

  Last reviewed September 17, 2026

• Telehealth or a local clinic for GLP-1 care?

  A neutral comparison of telehealth and in-person GLP-1 care: labs, exams, follow-up, continuity, state licensing rules and how programs charge.

  Last reviewed September 17, 2026

• My telehealth provider shut down or stopped serving my state: how to continue GLP-1 care

  What to do if your telehealth GLP-1 provider closes or leaves your state: get your records, avoid unsafe changes, and find a new prescriber.

  Last reviewed September 17, 2026

• How to check a compounding pharmacy's license

  Official license lookups for Texas, Colorado and New York, FDA's 503B outsourcing facility list, NABP tools, and red flags to watch for.

  Last reviewed September 17, 2026